Pomerantz LLP has filed a class action lawsuit against Sana Biotechnology (SANA) alleging the company made false and misleading statements about its financial capabilities and product development between March 17, 2023, and November 4, 2024. The lawsuit claims Sana misrepresented its ability to maintain operations and advance product candidates, subsequently reducing headcount and suspending development of key programs like SC291 and SC379.